Drug Trial News

RSS
NIH-supported first HIV vaccine efficacy study begins in South Africa

NIH-supported first HIV vaccine efficacy study begins in South Africa

Drug combination therapy delays progression of advanced breast cancer without side effects, study shows

Drug combination therapy delays progression of advanced breast cancer without side effects, study shows

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

Sanford opens new immunotherapy study on colorectal cancer

Sanford opens new immunotherapy study on colorectal cancer

New clinical study to examine novel dietary approach for TNBC

New clinical study to examine novel dietary approach for TNBC

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

Natural compound found in red wine can lower testosterone levels in women with PCOS

Natural compound found in red wine can lower testosterone levels in women with PCOS

Study to investigate clinical impact of new treatment for HFrEF patients

Study to investigate clinical impact of new treatment for HFrEF patients

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

UAB researchers launch first drug study to prevent onset of epilepsy in children with TSC

UAB researchers launch first drug study to prevent onset of epilepsy in children with TSC

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

Clinical study to test efficacy of different formulations of flu vaccine in heart failure patients

Clinical study to test efficacy of different formulations of flu vaccine in heart failure patients